1
1

index-about
社團法人台灣肝病醫療策進會Advancing Clinical Treatment – Liver Disease (ACT-LD) 為一國際權威肝病防治組織,成立目標即在於藉由提升民眾對於肝病的認知,加強醫學界對肝病相關重大進展的了解,來改善病人的照顧品質與治療結果。2004年台灣肝病醫療策進會於美國成立運作,2005年年初擴展到B型肝炎盛行之亞太地區,分別在亞太十四個國家成立分會。一向對台灣肝病防治不遺餘力、成績有目共睹的台灣,也於2005年11月29日正式宣布台灣分會成立。

家住南部C肝聚落 43歲男罹病「靠中藥撐15年」新藥3個月治癒

| 最新消息 | No Comments

▲在台南市肝病防治協會理事長鄭斌男(右)的協助下,患者吳先生…

鄰居都有C肝! 政府推偏鄉+基層診所醫療助攻

| 最新消息 | No Comments

    【健康醫療網/記者田柏升報導】40歲的吳大哥是土生土…

C肝新藥給付將見底 健保會挪出19億元

| 最新消息 | No Comments

C肝新藥今年元月起健保全面給付,不料近日傳出C肝新藥給付將見…

On 28 May, 194 Member States made a historic commitment to eliminate viral hepatitis by 2030. At the 69th World Health Assembly, governments unanimously voted to adopt the first ever Global Viral Hepatitis Strategy, signalling the greatest global commitment in viral hepatitis to date. The Strategy sets a goal of eliminating hepatitis B and C by 2030 and includes a set of prevention and treatment targets which, if reached, will reduce annual deaths by 65% and increase treatment to 80%, saving 7.1 million lives globally by 2030. Share this video and support NOhep.org on World Hepatitis Day (28 July 2016) to ensure governments countries honour their commitment to making the elimination of viral hepatitis our next greatest achievement.